§63-2-303.

§63-2-303.
   
   A. The Director of the Oklahoma State Bureau of Narcotics and
   Dangerous Drugs Control shall register an applicant to manufacture,
   distribute, dispense, prescribe, administer or use for scientific
   purposes controlled dangerous substances included in Schedules I
   through V of Section 2-101 et seq. of this title unless the Director
   determines that the issuance of such registration is inconsistent with
   the public interest. In determining the public interest, the following
   factors shall be considered:
   
   1. Maintenance of effective controls against diversion of particular
   controlled dangerous substances and any Schedule I or II substance
   compounded therefrom into other than legitimate medical, scientific or
   industrial channels, including examination of the fitness of his
   employees or agents to handle dangerous substances;
   
   2. Compliance with applicable state and local law;
   
   3. Prior conviction record of applicant under federal or state laws
   relating to the manufacture, distribution or dispensing of such
   substances;
   
   4. Furnishing by the applicant false or fraudulent material
   information in any application filed under Section 2-101 et seq. of
   this title;
   
   5. Past experience in the manufacture, distribution, dispensing,
   prescribing, administering or use for scientific purposes of
   controlled dangerous substances, and the existence in the
   establishment of effective controls against diversion;
   
   6. Denial, suspension or revocation of the applicant's federal
   registration to manufacture, distribute or dispense controlled
   dangerous substances as authorized by federal law; and
   
   7. Such other factors as may be relevant to and consistent with the
   public health and safety.
   
   Nothing herein shall be deemed to require individual licensed
   pharmacists to register under the provisions of the Uniform Controlled
   Dangerous Substances Act.
   
   B. Registration granted under subsection A of this section shall not
   entitle a registrant to manufacture, distribute, dispense, prescribe,
   administer or use for scientific purposes controlled dangerous
   substances in Schedule I or II other than those specified in the
   registration.
   
   C. Practitioners shall be registered to dispense, prescribe,
   administer or use for scientific purposes substances in Schedules II
   through V if they are authorized to carry on their respective
   activities under the laws of this state. A registration application by
   a practitioner who wishes to conduct research with Schedule I
   substances shall be accompanied by evidence of the applicant's federal
   registration to conduct such activity and shall be referred to the
   Medical Research Commission for advice. The Medical Research
   Commission shall promptly advise the Director concerning the
   qualifications of each practitioner requesting such registration.
   Registration for the purpose of bona fide research or of use for
   scientific purposes with Schedule I substances by a practitioner
   deemed qualified by the Medical Research Commission may be denied only
   on a ground specified in subsection A of Section 2-304 of this title
   or if there are reasonable grounds to believe that the applicant will
   abuse or unlawfully transfer such substances or fail to safeguard
   adequately such applicant's supply of such substances against
   diversion from legitimate medical or scientific use.
   
   D. 1. The Director shall initially permit persons to register who own
   or operate any establishment engaged in the manufacture, distribution,
   dispensing, prescribing, administering or use for scientific purposes
   of any controlled dangerous substances prior to June 4, 1991, and who
   are registered or licensed by the state. Fees for registration under
   this section shall be as follows:
   
   Practitioners and
   
   mid-level practitioners $35.00 per year
   
   of registration
   
   Home Care Agencies,
   
   Hospices & Home Care Services $35.00 annually
   
   Distributors $50.00 annually
   
   Manufacturers $100.00 annually
   
   2. A registrant shall be required to pay double the amount of the
   above-listed fee for any renewal of registration received more than
   sixty (60) days late.
   
   3. A Ten Dollar ($10.00) fee shall be charged for a duplicate
   registration certificate.
   
   E. Compliance by manufacturers and distributors with the provisions of
   the Federal Controlled Substances Act, 21 U.S.C., Section 801 et seq.,
   respecting registration, excluding fees, shall be deemed sufficient to
   qualify for registration under this act.